CRISPR screens reveal convergent targeting strategies against evolutionarily distinct chemoresistance in cancer
C. Zhong, W.-J. Jiang, Y. Yao, Z. Li, Y. Li, S. Wang, X. Wang, W. Zhu, S. Wu, J. Wang, S. Fan, S. Ma, Y. Liu, H. Zhang, W. Zhao, , T. Fei
This study identifies convergent therapeutic targets for chemoresistance in cancer using CRISPR screens across multiple drug conditions and cancer models.
bioRxiv · Apr 24, 2024Cancer Biology